Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Weesner, Jason Andrew
21  Ergebnisse:
Personensuche X
?
1

Glycosphingolipids within membrane contact sites influence ..:

Weesner, Jason Andrew ; Annunziata, Ida ; van de Vlekkert, Diantha.
FEBS Open Bio.  13 (2023)  9 - p. 1587-1600 , 2023
Link: https://doi.org/10.1002/..
 
?
2

Preclinical Enzyme Replacement Therapy with a Recombinant β..:

Weesner, Jason Andrew ; Annunziata, Ida ; Yang, Tianhong...
Cells.  11 (2022)  16 - p. 2579 , 2022
Link: https://doi.org/10.3390/..
 
?
3

MYC competes with MiT/TFE in regulating lysosomal biogenesi..:

Annunziata, Ida ; van de Vlekkert, Diantha ; Wolf, Elmar...
Nature Communications.  10 (2019)  1 - p. , 2019
Link: https://doi.org/10.1038/..
 
?
4

Glycosphingolipids within membrane contact sites influence ..:

Weesner, Jason Andrew ; Annunziata, Ida ; van de Vlekkert, Diantha.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476575/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
5

Preclinical Enzyme Replacement Therapy with a Recombinant β..:

Weesner, Jason Andrew ; Annunziata, Ida ; Yang, Tianhong...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406850/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

Glycosphingolipids within membrane contact sites influence ..:

Jason Andrew Weesner ; Ida Annunziata ; Diantha van deVlekkert.
https://doi.org/10.1002/2211-5463.13605.  , 2023
Link: https://doi.org/10.1002/..
 
?
7

Preclinical Enzyme Replacement Therapy with a Recombinant β..:

Jason Andrew Weesner ; Ida Annunziata ; Tianhong Yang...
https://www.mdpi.com/2073-4409/11/16/2579.  , 2022
Link: https://doi.org/10.3390/..
 
?
8

Preclinical Enzyme Replacement Therapy with a Recombinant β..:

Jason Andrew Weesner ; Ida Annunziata ; Tianhong Yang...
Cellular Pathology.  , 2022
Link: https://doi.org/10.3390/..
 
?
9

MYC competes with MiT/TFE in regulating lysosomal biogenesi..:

Ida Annunziata ; Diantha van de Vlekkert ; Elmar Wolf...
https://doi.org/10.1038/s41467-019-11568-0.  , 2019
Link: https://doi.org/10.1038/..
 
?
10

MYC competes with MiT/TFE in regulating lysosomal biogenesi..:

Annunziata, Ida ; van de Vlekkert, Diantha ; Wolf, Elmar...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689058/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
11

AAV-mediated gene therapy for sialidosis:

van de Vlekkert, Diantha ; Hu, Huimin ; Weesner, Jason A....
Molecular Therapy.  32 (2024)  7 - p. 2094-2112 , 2024
Link: https://doi.org/10.1016/..
 
?
12

Altered GM1 catabolism affects NMDAR-mediated Ca2+ signalin..:

Weesner, Jason A. ; Annunziata, Ida ; van de Vlekkert, Diantha...
Cell Reports.  43 (2024)  5 - p. 114117 , 2024
Link: https://doi.org/10.1016/..
 
?
13

AAV-mediated gene therapy for galactosialidosis: A long-ter..:

Fremuth, Leigh E. ; Hu, Huimin ; van de Vlekkert, Diantha...
Molecular Genetics and Metabolism.  138 (2023)  2 - p. 107105 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Preclinical enzyme replacement therapy with a recombinant β..:

Weesner, Jason A. ; van de Vlekkert, Diantha ; Acosta, Walter L....
Molecular Genetics and Metabolism.  138 (2023)  2 - p. 107356 , 2023
Link: https://doi.org/10.1016/..
 
?
15

AAV-mediated gene therapy in a mouse model of sialidosis:

van de Vlekkert, Diantha ; Hu, Huimin ; Weesner, Jason A...
Molecular Genetics and Metabolism.  138 (2023)  2 - p. 107342 , 2023
Link: https://doi.org/10.1016/..
 
1-15